NCT04747912 2026-03-30Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)University of ChicagoPhase 2 Suspended25 enrolled
NCT00044733 2006-05-18Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell TransplantWyeth is now a wholly owned subsidiary of PfizerPhase 2 Completed38 enrolled